CY1119525T1 - Συνθεση 3-(5-αμινο-2-μεθυλ-4-οξοκιναζολιν-3(4η)-υλ)πιπε-ριδινο-2,6-διονης - Google Patents

Συνθεση 3-(5-αμινο-2-μεθυλ-4-οξοκιναζολιν-3(4η)-υλ)πιπε-ριδινο-2,6-διονης

Info

Publication number
CY1119525T1
CY1119525T1 CY20171101119T CY171101119T CY1119525T1 CY 1119525 T1 CY1119525 T1 CY 1119525T1 CY 20171101119 T CY20171101119 T CY 20171101119T CY 171101119 T CY171101119 T CY 171101119T CY 1119525 T1 CY1119525 T1 CY 1119525T1
Authority
CY
Cyprus
Prior art keywords
amino
methyl
oxokinazolin
dionis
ridino
Prior art date
Application number
CY20171101119T
Other languages
Greek (el)
English (en)
Inventor
Alexander L. Ruchelman
Benjamin M. Cohen
Anusuya Choudhury
Matthew M. KREILEIN
William W. Leong
Hon-Wah Man
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of CY1119525T1 publication Critical patent/CY1119525T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CY20171101119T 2013-05-01 2017-10-26 Συνθεση 3-(5-αμινο-2-μεθυλ-4-οξοκιναζολιν-3(4η)-υλ)πιπε-ριδινο-2,6-διονης CY1119525T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361818254P 2013-05-01 2013-05-01
PCT/US2014/036083 WO2014179416A1 (en) 2013-05-01 2014-04-30 Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione

Publications (1)

Publication Number Publication Date
CY1119525T1 true CY1119525T1 (el) 2018-03-07

Family

ID=50885008

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101119T CY1119525T1 (el) 2013-05-01 2017-10-26 Συνθεση 3-(5-αμινο-2-μεθυλ-4-οξοκιναζολιν-3(4η)-υλ)πιπε-ριδινο-2,6-διονης

Country Status (26)

Country Link
US (3) US9067912B2 (enExample)
EP (2) EP3199532A1 (enExample)
JP (2) JP6490055B2 (enExample)
KR (1) KR20160003228A (enExample)
CN (2) CN105377831B (enExample)
AR (1) AR096165A1 (enExample)
AU (2) AU2014260011A1 (enExample)
CA (1) CA2910971A1 (enExample)
CY (1) CY1119525T1 (enExample)
DK (1) DK2991976T3 (enExample)
ES (1) ES2645944T3 (enExample)
HR (1) HRP20171535T1 (enExample)
HU (1) HUE034770T2 (enExample)
LT (1) LT2991976T (enExample)
MX (1) MX363652B (enExample)
NZ (1) NZ628322A (enExample)
PH (1) PH12015502477A1 (enExample)
PL (1) PL2991976T3 (enExample)
PT (1) PT2991976T (enExample)
RS (1) RS56565B1 (enExample)
RU (1) RU2015151359A (enExample)
SG (1) SG11201508836XA (enExample)
SI (1) SI2991976T1 (enExample)
SM (1) SMT201700513T1 (enExample)
TW (1) TW201536766A (enExample)
WO (1) WO2014179416A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52349B (sr) 2006-09-26 2012-12-31 Celgene Corporation 5-supstituisani derivati hinazolinona kao antitumorski agensi
CA2829570C (en) 2011-03-11 2019-05-07 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
EP2892887B1 (en) 2012-09-04 2020-07-15 Celgene Corporation Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
US10973822B2 (en) 2015-07-02 2021-04-13 Celgene Corporation Combination therapy for treatment of hematological cancers and solid tumors
CN106083622B (zh) * 2016-06-16 2018-06-19 常州齐晖药业有限公司 一种甲苯咪唑中间体3,4-二氨基二苯甲酮的制备方法
US20180258064A1 (en) * 2017-03-07 2018-09-13 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
CN113101295A (zh) * 2020-03-20 2021-07-13 上海疆云医疗健康科技有限公司 二苯乙烯类似物在治疗糖尿病肾脏疾病中的用途
KR20240055046A (ko) * 2021-09-02 2024-04-26 신톤 비.브이. 오시머티닙을 제조하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2032538A2 (en) * 2006-06-08 2009-03-11 Array Biopharma, Inc. Quinoline compounds and methods of use
RS52349B (sr) * 2006-09-26 2012-12-31 Celgene Corporation 5-supstituisani derivati hinazolinona kao antitumorski agensi
RU2017120977A (ru) * 2011-03-11 2018-11-15 Селджин Корпорейшн Способ лечения рака с использованием 3-(5-амино-2-метил-4-оксо-4h-хиназолин-3-ил)пиперидин-2,6-диона
CA2829570C (en) * 2011-03-11 2019-05-07 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
EP2892887B1 (en) * 2012-09-04 2020-07-15 Celgene Corporation Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
EP2943201B2 (en) * 2013-01-14 2020-07-29 Deuterx, LLC 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives

Also Published As

Publication number Publication date
RS56565B1 (sr) 2018-02-28
NZ628322A (en) 2017-06-30
CN107935994A (zh) 2018-04-20
US9303014B2 (en) 2016-04-05
CN105377831B (zh) 2018-02-02
KR20160003228A (ko) 2016-01-08
JP6490055B2 (ja) 2019-03-27
RU2015151359A (ru) 2017-06-06
MX2015015073A (es) 2016-03-03
EP2991976A1 (en) 2016-03-09
SI2991976T1 (sl) 2017-11-30
LT2991976T (lt) 2017-10-25
CA2910971A1 (en) 2014-11-06
CN105377831A (zh) 2016-03-02
JP2019069958A (ja) 2019-05-09
SMT201700513T1 (it) 2018-01-11
US20150274694A1 (en) 2015-10-01
US9067912B2 (en) 2015-06-30
US9266858B2 (en) 2016-02-23
PH12015502477A1 (en) 2016-02-22
MX363652B (es) 2019-03-28
AR096165A1 (es) 2015-12-09
ES2645944T3 (es) 2017-12-11
WO2014179416A1 (en) 2014-11-06
US20140330016A1 (en) 2014-11-06
EP3199532A1 (en) 2017-08-02
HUE034770T2 (hu) 2018-02-28
PT2991976T (pt) 2017-11-14
HRP20171535T1 (hr) 2017-11-17
EP2991976B1 (en) 2017-09-20
PL2991976T3 (pl) 2018-01-31
SG11201508836XA (en) 2015-11-27
US20160009685A1 (en) 2016-01-14
JP2016517886A (ja) 2016-06-20
TW201536766A (zh) 2015-10-01
AU2017200965A1 (en) 2017-03-02
DK2991976T3 (da) 2017-11-06
AU2014260011A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
CY1119525T1 (el) Συνθεση 3-(5-αμινο-2-μεθυλ-4-οξοκιναζολιν-3(4η)-υλ)πιπε-ριδινο-2,6-διονης
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
CY1121592T1 (el) Μια στερεη μορφη της υδροχλωρικης (s)-3-(4-((4-μορφολινομεθυλ)βενζυλ)οξυ)-1-οξοϊσοϊνδολιν-2-υλ)πιπεριδινο-2,6-διονης
IL256898B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
ME03432B (me) Piridonski derivati korišćeni kao inhibitori kinaze reorganizovane tokom transfekcije (ret)
EP2943201A4 (en) 3- (5-SUBSTITUTED 4-OXOCHINAZOLIN-3 (4H) -YL) -3-DEUTERO-PIPERIDINE-2,6-DION DERIVATIVES
EA201791304A1 (ru) Производные изохинолина для лечения вич
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
MX2016011992A (es) Derivados de piperidina-diona.
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
ECSP15043696A (es) Compuestos de heteroarilo y sus usos
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
MX2015011514A (es) Compuestos de heteroarilo y sus usos.
CR20150524A (es) Compuestos de heteroarilo y sus usos
EA201401054A1 (ru) N-циклиламиды в качестве нематоцидов
EA201591805A1 (ru) Оксабицикло [2.2.2] кислоты - модуляторы gpr120
PH12017501816A1 (en) Azabensimidazoles and their use as amp a receptor modulators
EA201590272A1 (ru) Пероральные дозированные формы для модифицированного высвобождения, содержащие руксолитиниб
IL244494B (en) Formulations of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindoline-2-yl)piperidine-6,2-dione
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
BR112017028549A2 (pt) derivados de pirimidina como inibidores de btk e usos dos mesmos
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
CY1120812T1 (el) Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου
EA201790373A1 (ru) Способы получения модуляторов toll-подобных рецепторов
EA201690908A1 (ru) Пиразолопиримидиновые соединения